✦ LIBER ✦

86 Role of tumor necrosis factor and nitric oxide in portal hypertension

✍ Scribed by Nicholas J. Skill; Nicholas G. Heodorakis; Yining N. Wang; Matthew M. Metz; Eileen M. Redmond; James V. Sitzmann

Book ID: 119529995
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 127 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80129-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor α regulates nitric

Tumor necrosis factor α regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats

✍ Masayuki Ohta; Andrzej S. Tarnawski; Rabiha Itani; Rama Pai; Morimasa Tomikawa; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Anti-tumor necrosis factor ␣ (TNF-␣) treatment decreases nitric oxide (NO) synthesis and ameliorates the hyperdynamic circulation in portal hypertensive rats. We have recently demonstrated that nitric oxide synthase isoform 3 (NOS3) is overexpressed in portal hypertensive gastric mucosa and that res

Role of tumor necrosis factor-α and nitr

Role of tumor necrosis factor-α and nitric oxide in luteolysis in cattle

✍ Dariusz J. Skarzynski; Jerzy J. Jaroszewski; Kiyoshi Okuda 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Tumor Necrosis Factor-α, Interleukin-1β

Tumor Necrosis Factor-α, Interleukin-1β and Nitric Oxide: Induction of Liver Megamitochondria in Prehepatic Portal Hypertensive Rats

✍ Isabel Prieto; Fulgencio Jiménez; Maria-Angeles Aller; Maria-Paz Nava; Elena Var 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 146 KB

Thalidomide inhibits tumor necrosis fact

Thalidomide inhibits tumor necrosis factor α, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats

✍ J C Lopez-Talavera; G Cadelina; J Olchowski; W Merrill; R J Groszmann 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 281 KB

Portal hypertension accompanied by anatomic or served in portal hypertension with liver failure or extenfunctional portal-systemic shunting very often is assosive portal-systemic shunting. Tumor necrosis factor a ciated with a hyperdynamic circulatory state. The so-(TNF) causes marked hypotension in

Thalidomide inhibits tumor necrosis fact

Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats

✍ JC Lopez-Talavera; G Cadelina; J Olchowski; W Merrill; RJ Groszmann 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Increased angiogenesis in portal hyperte

Increased angiogenesis in portal hypertensive rats: Role of nitric oxide

✍ Lazar T. Sumanovski; Edouard Battegay; Michael Stumm; Maaike van der Kooij; Corn 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Systemic and especially splanchnic arterial vasodilation accompany chronic portal hypertension. Different soluble mediators causing this vasodilation have been proposed, the strongest evidence being for nitric oxide (NO). No data exist if structural vascular changes may partly account for this vasod